Research article
Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
-
* Corresponding author: Thomas Dörner thomas.doerner@charite.de
Arthritis Research & Therapy 2006, 8:R74 doi:10.1186/ar1942
See related commentary by Eisenberg: http://arthritis-research.com/content/8/3/108
No comments have yet been made on this article.